| INTRODUC TI ON
Isolated premature ventricular complexes (PVCs) are the most common arrhythmias observed in patients even if without structural heart disease. 1 Many patients with PVCs often experience disabling symptoms and sometimes need long-term antiarrhythmic medications. However, the latter may have adverse effects, such as the increasing the mortality, probably due to their proarrhythmic effects, even though markedly suppressing the occurrence of PVCs. 2 In recent years, radiofrequency catheter ablation (RFCA) has proven to be a safe and successful therapy for arrhythmias including PVCs. 3 Moreover, we previously reported that RFCA of PVCs from the right ventricular outflow tract (RVOTPVCs), which is one of the most common type of PVCs, improves left ventricular (LV) dilation and the clinical status in patients without structural heart disease. 1 On the other hand, PVCs from near the His-bundle are comparably uncommon. 3 However, they also often occur with intolerable symptoms. Thus, the aim of this study was to investigate the effects of RFCA and the clinical and electrophysiological characteristics in symptomatic patients with PVCs from near the His-bundle. velocity (e') and index E/e' ratio using tissue Doppler imaging, tricuspid regurgitation velocity (TRV), and left atrial volume index (LAVI), were measured. All the echocardiography values were recorded during sinus rhythm, but not during PVC beats, nor post-PVC beats. The serum brain natriuretic peptide (BNP) concentration and New York Heart Association (NYHA) functional class using a specific activity scale were evaluated on admission and 6 months after the successful RFCA.
| MATERIAL AND ME THODS

| Study population and laboratory analysis
| Classification of PVCs from near the
His-bundle (Figure 1A,B)
The PVCs from near the His-bundle were divided into two groups on the basis of the site of the PVC origin. The His-PVC group was defined as having a site of the origin of the PVCs located near the His-bundle within at least 10 mm of the largest His-bundle potential 4 ( Figure 1A ). The PVC from the right interventricular septum (RIS) (RIS-PVC) group was defined as having a site of the origin of the PVCs located near the His-bundle, within 25 mm, but without the largest His-bundle potential ( Figure 1B ). Ventricular tachycardia (VT) was defined by the standard electrocardiographic criteria of at least three consecutive PVCs at a rate of >120 beats per minute. No patients had any VT or atrial tachyarrhythmias including atrial fibrillation, atrial flutter, atrial tachycardia, or paroxysmal supraventricular tachycardia, or received hemodialysis during this study.
| Mapping and catheter ablation procedure
All procedures were performed after written informed consent was obtained. Antiarrhythmic drugs were discontinued at least 3 days before the procedure. The QRS duration and peak deflection index (PDI) 5 were measured before the RFCA. RFCA was performed as described previously. Kohden Co., Tokyo, Japan) was performed to induce the culprit PVC. An optimal pace map was defined as a match of all 12 surface leads by comparing the R/S ratio and subtle notching in the QRS complex during pacing. An identical match was necessary in at least 11 of 12 leads. Further, based on the findings of the electro-anatomical mapping and an optimal pace map, radiofrequency energy was delivered at the site of the unipolar potentials from the ablation catheter demonstrating a QS pattern and bipolar potentials from the tip of the ablation catheter preceding the QRS in 
| Statistical analysis
The numerical results are expressed in the text as the mean ± standard deviation. Paired data was compared using Fisher's exact test and Student t tests.
A comparison of time-related changes was performed by using 
| Comparison of the clinical characteristics between the His-PVC group and RIS-PVC group on admission (Table 1)
There were no statistical differences among all factors including the age (71 ± 2 vs 68 ± 4; P = 0.138), BMI (23.4 ± 1.2 vs 24.6 ± 1.3 kg/m 2 ; P = 0.138), serum creatinine (0.91 ± 0.05 vs 0.92 ± 0.07; P = 0.538), prevalence of being male (83% vs 75%; P = 1.000), co-existence of ex-or current smoking (50% vs 75%; P = 0.580), ALSRD (83% vs 88%; P = 1.000) including hypertension (67% vs 63%; P = 1.000), dyslipidemia (30% vs 63%; P = 1.000), and DM (33% vs 13%; P = 0.538), prevalence of symptoms including palpitations (67% vs 75%; P = 1.000), general fatigue (50% vs 25%; P = 0.580), chest discomfort (33% vs 63%; P = 0.592), and fainting (0% vs 0%), and medications including beta-blockers (50% vs 75%; P = 0.580), calcium channel blockers (33% vs 0%; P = 0.165), class I agents (17% vs 25%;P = 1.000) and no
medication (17% vs 13%; P = 1.000), between the His-PVC and RIS-PVC group.
| Twenty four hour
Holter monitoring, NYHA functional class, and serum BNP concentration, in patients with PVCs from near the His-bundle before and after the RFCA (Table 2) The %PVCs was calculated as: 100*[number of PVCs/number of total heart beats per day]. There was no statistical difference in the number of total heart beats (106 694 ± 3176 vs 104 849 ± 2671 beats/day; P = 0.358) between that before and after the RFCA.
RFCA of PVCs from near the His-bundle steadily and significantly decreased and improved the total PVC per day count (from 17 999 ± 3306 to 108 ± 35 beats/day; P < 0.001), %PVCs (from 17 ± 3 to 0.10 ± 0.03%; P < 0.01), NYHA functional class (from 1.86 ± 0.14 to 1.00 ± 0.00; P < 0.001), and serum BNP concentration (from 63 ± 14 to 18 ± 3 pg/mL; P = 0.004) as compared to that before the RFCA.
| Comparison of the 24 hour Holter monitoring,
NYHA functional class, and serum BNP concentration, between the His-PVC group and RIS-PVC group before and after the RFCA (Table 2) Before the RFCA, there was no statistical difference in the number of total heart beats (110 446 ± 2693 vs 103 881 ± 5125 beats/day; to 109 ± 43 beats/day; P = 0.004), %PVCs (from 18 ± 3 to 0.01 ± 0.05%; P < 0.001 and from 16 ± 4 to 0.01 ± 0.04%; P = 0.003), NYHA functional class (from 1.67 ± 0.21 to 1.00 ± 0.00; P = 0.010 and from 2.00 ± 0.19 to 1.00 ± 0.00; P < 0.001), and serum BNP concentration (from 55 ± 15 to 16 ± 6 pg/mL; P = 0.058 and from 68 ± 23 to 18 ± 2 pg/mL; P = 0.038) 
Parameters of left ventricular diastolic dysfunction
Before RFCA E/A ratio 1.09 ± 0.10 0.91 ± 0.13 1.23 ± 0.14 0.138
DcT (ms) 239 ± 9 253 ± 6 228 ± 15 0.538
Index E/e' ratio 13 ± 1 13 ± 2 14 ± 2 0.625
Mean lateral e' velocity (cm/s) 5.9 ± 0.4 5.8 ± 0.5 5.9 ± 0.6 1.000
Tricuspid regurgitation velocity (m/s) 2.3 ± 0.1 2.3 ± 0.1 2.3 ± 0.1
1.000
Left atrial volume index (mL/m 2 ) 28 ± 3 24 ± 5 30 ± 5 0.592
After RFCA E/A ratio 1.12 ± 0.10 0.98 ± 0.13 1.22 ± 0.14 0.165
DcT (ms) 231 ± 9 248 ± 7 219 ± 13 0.138
Index E/e' ratio 13 ± 1 12 ± 2 14 ± 1 0.593
Mean lateral e' velocity (cm/s) 5.9 ± 0. PVC, premature ventricular contraction; RFCA, radiofrequency catheter ablation; LVEF, left ventricular ejection fraction; LVDd, left ventricular end-diastolic internal dimension; LVDs, left ventricular end-systolic internal dimension; RVD, right ventricular internal dimension; E/A ratio, mitral early to late diastolic flow velocity ratio; DcT, mitral E wave deceleration time.
*P < 0.05 vs Before RFCA.
in the His-PVC and RIS-PVC groups, respectively, as compared to that before the RFCA. After the RFCA, there was no statistical difference in the number of total heart beats (105 756 ± 3102 vs 104 169 ± 4228 beats/day; P = 0.822), total PVCs per day (106 ± 62 vs 109 ± 43 beats/ day; P = 1.000), %PVCs (0.10 ± 0.05 vs 0.10 ± 0.04%; P = 1.000), NYHA functional class (1.00 ± 0.00 vs 1.00 ± 0.00; P = 1.000), and serum BNP concentration (16 ± 6 vs 18 ± 2 pg/mL; P = 0.785) between the His-PVC and RIS-PVC groups.
| Echocardiography and diastolic dysfunction in patients with
PVCs from near the His-bundle before and after the RFCA (Table 3) RFCA of PVCs from near the His-bundle could steadily and significantly improve the LVEF (from 64 ± 1 to 67 ± 1%; P = 0.022) and LVDd (from 47 ± 1 to 44 ± 1 mm; P = 0.045) as compared to that before the RFCA. Hovever, there was no statistical difference in the LVDs (30 ± 1 vs 28 ± 1 mm; P = 0.335) and RVD (15 ± 1 vs 15 ± 1 mm; P = 1.000)
between that before and after the RFCA. Moreover, RFCA of PVCs from near the His-bundle could not improve the LV diastolic dysfunction including the parameters of the E/A ratio (from 1.09 ± 0.10 to 1.12 ± 0.10; P = 1.000), DcT (from 239 ± 9 to 231 ± 9 ms; P = 0.558), Index E/e' (from 13 ± 1 to 13 ± 1; P = 1.000), mean lateral e' velocity (from 5.9 ± 0.4 to 5.9 ± 0.3 cm/s; P = 1.000), TRV (from 2.3 ± 0.1 to 2.3 ± 0.1 m/s; P = 1.000), and LAVI (from 28 ± 3 to 27 ± 3 mL/m 2 ; P = 0.940), between that before and after the RFCA.
| Comparison of the echocardiography and diastolic dysfunction between the His-PVC and RIS-PVC groups before and after the RFCA (Table 3)
There was no statistical difference in the LVEF (from 64 ± 2 to 68 ± 1%; P = 0.094 and from 64 ± 2 to 67 ± 1%; P = 0.124), LVDd (from 47 ± 2 to 45 ± 1 mm; P = 0.284 and from 47 ± 2 to 43 ± 1 mm; P = 0.112), LVDs (from 31 ± 1 to 28 ± 1 mm; P = 0.229 and from 29 ± 1 to 27 ± 1 mm; P = 0.293), RVD (from 15 ± 1 to 15 ± 1 mm; P = 1.000 and from 15 ± 1 to 15 ± 1 mm; P = 1.000), LV diastolic dysfunction including the parameters of the E/A ratio (from 0.91 ± 0.13 to 0.98 ± 0.13; P = 0.685 and from 1.23 ± 0.14 to 1.22 ± 0.14; P = 1.000), DcT (from 253 ± 6 to 248 ± 7 ms; P = 0.594 and from 228 ± 15 to 219 ± 13 ms; P = 0.642), Index E/e' (from 13 ± 2 to 12 ± 2; P = 1.000 and from 14 ± 2 to 14 ± 1; P = 1.000), mean lateral e' velocity (from 5.8 ± 0.5 to 6.0 ± 0.4 cm/s; P = 0.757 and from 5.9 ± 0.6 to 5.9 ± 0.5 cm/s; P = 1.000), TRV (from 2.3 ± 0.1 to 2.4 ± 0.1 m/s; P = 0.352 and from 2.3 ± 0.1 to 2.3 ± 0.1 m/s; P = 1.000), and LAVI (from 24 ± 5 to 25 ± 5 mL/m 2 ; P = 1.000 and from 30 ± 5 to 30 ± 4 mL/m 2 ; P = 1.000), between that before and after the RFCA in both the His-PVC and RIS-PVC groups, respectively. There was no statistical difference in the LVEF (64 ± 2 vs 64 ± 2%; P = 1.000 and 68 ± 1 vs 67 ± 1%; P = 1.000), LVDd (47 ± 2 vs 47 ± 2 mm; P = 1.000 and 45 ± 1 vs 43 ± 1 mm; P = 0.583), LVDs (31 ± 1 vs 29 ± 1 mm; P = 0.583 and 28 ± 1 vs 27 ± 1 mm; P = 0.592), RVD (15 ± 1 vs 15 ± 1 mm; P = 1.000 and 15 ± 1 vs 15 ± 1 mm; P = 1.000), LV diastolic dysfunction including the parameters of the E/A ratio (0.91 ± 0.13 vs 1.23 ± 0.14; P = 0.138 and 0.98 ± 0.13 vs 1.22 ± 0.14; P = 0.165), DcT (253 ± 6 vs 228 ± 15 ms; P = 0.538 and 248 ± 7 vs 219 ± 13 ms; P = 0.138), Index E/e' (13 ± 2 vs 14 ± 2; P = 0.625 and 12 ± 2 vs 14 ± 1; P = 0.593), mean lateral e' velocity (5. 
His-PVC (n = 6) RIS-PVC (n = 8) P value
| Comparison of the electrophysiological findings between the His-PVC and RIS-PVC groups (Table 4 and Figure 1C-E)
During RFCA procedures, no patients required a radiofrequency energy delivery from the left ventricle or aortic cusps in either group. The QRS duration (111 ± 5 vs 125 ± 3 ms; P = 0.026), accordance rate of the QRS polarity between sinus rhythm and PVCs, average distance between the successful ablation site and Hisbundle (100 ± 0 vs 84 ± 4%; P = 0.005), and distance between the successful ablation site and His-bundle (8.0 ± 0.6 vs 15.9 ± 1.3 mm; P < 0.001), were significantly narrower, higher, and shorter, in the His-PVC group than RIS-PVC group. There was no statistical difference in the PDI between the two groups (0.57 ± 0.05 vs 0.59 ± 0.05; P = 1.000). The successful ablation sites in the His-PVC group (red circle; n = 6) and RIS-PVC group (blue circle; n = 8) are demonstrated in Figure 1C . The scatter plot analysis revealed a significant relationship between the accordance rate of the QRS polarity between sinus rhythm and His-PVCs and the distance between the successful ablation site and His-bundle (P < 0.001, r = 0.876) ( Figure 1D ), but not between the accordance rate of the QRS polarity between sinus rhythm and the QRS duration of the His-PVCs (P = 0.159) ( Figure 1E ). The prevalence of the use of irrigation catheters tended to be lower in the His-PVC group than RIS-PVC group (17% vs 63%; P = 0.138). Because radiofrequency energy had to be delivered near the His-bundle in the His-PVC group, 4 mm-tip catheters were used (83% vs 38%; P = 0.138) in order to avoid AV block.
Although the initial success rates were 100% in both groups, recurrence of culprit PVCs was observed in two (33%) and one (13%) patients during the follow-up in the His-PVC and RIS-PVC groups, respectively. However, all three patients underwent a repeat RCFA with successful results and no recurrence. Although only one patient suffered from transient AV block during the radiofrequency energy deliveries in the His-PVC group, no patients suffered from any procedure-related permanent adverse complications in either group.
| D ISCUSS I ON
| Clinical characteristics in patients with PVCs from near the His-bundle
We demonstrated that there was a higher prevalence of being male, elderly, slightly obese, and having a current and/or history of smoking, complications from ALSRD including hypertension, dyslipidemia, and DM, and CVDs including CAD, CBVD, and cardiomyopathy, LV diastolic dysfunction in patients with PVCs from near the His-bundle compared to RVOT-and other PVCs, as previously reported. 1, 7 These findings may possibly indicate that the complications from ALSRD and/or CVD contributing to LV diastolic dysfunction may be induced and accelerated by a higher age and bad life style. Thus, the probable mechanisms of PVCs from near the His-bundle may be associated with these conditions. In this study, although there were no patients with PVCs from the LV near His-bundle, it is unfortunately unknown why they occurred in the RV near the His-bundle. Moreover, the underlying intracellular mechanisms of the PVCs from near the Hisbundle could not be clarified.
| Electrocardiogram characteristics of PVCs from near the His-bundle
An RVOT-PVC was defined as having a characteristic electrocardiographic appearance with (i) a left bundle branch block (LBBB) pattern in precordial leads, (ii) tall R waves in the inferior leads, and (iii) an early precordial transitional zone in leads V3-V4, as previously described. 1 A PVC from near the His-bundle was defined as having a characteristic electrocardiographic appearance with (i) a monophasic tall R pattern in lead I, (ii) low R waves in leads II, III, and aVF, particularly lower R waves in lead III than lead II, (iii) R waves in lead aVL, relatively narrow QRS duration, (iv) QS pattern in lead V1, (v) an early precordial transitional zone in leads V2-V3, and (vi) tall R waves in leads V5 and V6, as previously described. 3, 4 The PVCs from near His-bundle were differentiated from RVOT-PVCs by recognizing these electrocardiographic chatacteristics.
| RFCA of PVCs from near the His-bundle
Because the PDI 
| Selection of the ablation catheter for RFCA of PVCs from near the His-bundle
The QRS duration (111 ± 5 vs 125 ± 3 ms; P = 0.026), was significantly narrower in the His-PVC group than RIS-PVC group (Table 4) . The scatter plot analysis revealed a significant relationship between the accordance rate of the QRS polarity between sinus rhythm and PVCs from near the His-bundle and the distance between the successful ablation site and His-bundle (P < 0.001, r = 0.876) ( Figure 1D 
| Clinical benefits of RFCA of PVCs from near the His-bundle
Similar to what we previously reported about RFCA of RVOT-PVCs, (Tables 2 and 3 ). Unfortunately, RFCA of PVCs from near the His-bundle could not improve the LV diastolic dysfunction parameters (Table 3) . It is still unclear whether the cause of LV diastolic dysfunction may be PVCs from near the His-bundle or myocardial degenerative changes resulting from complications from ALSRD and/ or CVD. Because the serum BNP concentration improved 6 months after the RFCA of the PVCs from near the His-bundle (Table 2) , the LV diastolic dysfunction may improve after the long-term follow-up.
| LIMITATI ON S OF THE S TUDY
Although our study was a multi-center trial, it was limited by a relatively small number of patients because PVCs from near the His-Bundle are comparatively rare arrhythmias. The patients in this study were also limited by being symptomatic and an RFCA of PVCs from near the His-Bundle being capable from only a right-sided approach. Thus, the effect of the RFCA of PVCs from near the HisBundle in asymptomatic patients was unfortunately unknown in this study. Moreover, our study could not clarify the underlying intracellular mechanisms of the PVCs from near the His-Bundle or longterm clinical benefit of RFCA of PVCs from near the His-Bundle.
Whether our results can safely be extrapolated to the inclusion of a larger number of patients and whether a longer follow-up period for these patients is needed should be determined in further studies. Recent advancement in new technologies, including the Arctic Front Advance cryo-ablation catheter, has facilitated a stable lesion creation near the His-bundle and can be considered a safer source of energy as compared to RF energy in such patients at high risk of AV block. 8 However, we could not use that device because it could be used in only a limited number of facilities in Japan at that time. However, they currently are commercially available all over the world and may improve and help in the RFCA procedure.
| CONCLUSIONS
The clinical characteristics in patients with symptomatic PVCs from near the His-bundle were a higher prevalence of being male, elderly, 
